Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial
暂无分享,去创建一个
F. Lévi | S. Giacchetti | P. Innominato | C. Focan | P. Chollet | R. Adam | M. Bouchahda | A. Karaboué | A. Ballesta | C. Garufi | Qi Huang | Annabelle Ballesta